Hi there!
We track 49,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Crane Biosciences
Crane Biosciences develops gene and RNA therapies that use red blood cell–derived nanoparticles to deliver treatments while avoiding immune detection. The company engineers RBC-derived nanoparticles…
Crane Biosciences
Crane Biosciences develops gene and RNA therapies that use red blood cell–derived nanoparticles to deliver treatments while avoiding immune detection. The company engineers RBC-derived nanoparticles…
TL;DR
Core technology: Red blood cell-derived nanoparticles (RBCNPs) for RNA/gene delivery
Clinical focus: Gene and RNA therapies targeting genetic and hard-to-treat diseases
Funding: Pre-Seed announced 2024-06-03; lead investor: Norrsken Accelerator
Founded: 2022
Research base: Based at Imperial College London with academic and accelerator partners
Company Overview
Problem Domain
Delivery of RNA and gene therapies for diseases caused by genetic mutations and other hard-to-treat conditions.
Founded
2022
Industry
Biotechnology
Tech Stack
Funding Track Record
125000 USD
Investor Signal
“Norrsken Accelerator”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 49,000+ startups and their open roles. No spam. No gamification. Just jobs.
49,000+
Startups
44,000+
Open Roles
0+
New This Week